tiprankstipranks
CytomX Therapeutics Reports Q3 Progress and Growth
PremiumCompany AnnouncementsCytomX Therapeutics Reports Q3 Progress and Growth
2M ago
CytomX Therapeutics reports Q3 EPS 7c, consensus (17c)
Premium
The Fly
CytomX Therapeutics reports Q3 EPS 7c, consensus (17c)
2M ago
CTMX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CTMX Upcoming Earnings Report: What to Expect?
2M ago
CytomX Therapeutics Appoints Chris Ogden as New CFO
PremiumCompany AnnouncementsCytomX Therapeutics Appoints Chris Ogden as New CFO
7M ago
CytomX Therapeutics promotes Chris Ogden to CFO
Premium
The Fly
CytomX Therapeutics promotes Chris Ogden to CFO
7M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
8M ago
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
PremiumThe FlyWedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a data
8M ago
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
Premium
The Fly
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
8M ago
CytomX Therapeutics announces initial data from CX-904 trial
Premium
The Fly
CytomX Therapeutics announces initial data from CX-904 trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100